Brinker Capital Investments’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-9,668
Closed -$316K 1389
2021
Q4
$316K Buy
9,668
+1,470
+18% +$59.1K ﹤0.01% 1225
2021
Q3
$295K Hold
8,198
﹤0.01% 1144
2021
Q2
$295K Buy
8,198
+3,011
+58% +$111K ﹤0.01% 1196
2021
Q1
$202K Sell
5,187
-4,251
-45% -$191K ﹤0.01% 1150
2020
Q4
$381K Buy
+9,438
New +$434K 0.01% 893

Other funds holding GDRX

Brinker Capital Investments's GDRX Position: Q1 2022 in Review

Brinker Capital Investments sold out of GoodRx Holdings (GDRX) in Q1 2022, closing a stake of 9,668 shares — an estimated $316K sold.

Brinker Capital Investments first reported a position in GDRX in Q4 2020 and held it in 5 quarters. The position peaked at $381K in Q4 2020. 167 funds tracked by Wall St. Rank hold GDRX as of Q1 2022.

  • Brinker Capital Investments reported no remaining GoodRx Holdings position as of Q1 2022 after selling out during the quarter.
  • Brinker Capital Investments sold 9,668 GoodRx Holdings shares in Q1 2022, an estimated $316K.
  • Brinker Capital Investments first reported a position in GoodRx Holdings in Q4 2020 and held it in 5 quarters.
  • Brinker Capital Investments's GoodRx Holdings position peaked at $381K in Q4 2020.
  • 167 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2022.

Based on Brinker Capital Investments's 13F filing for Q1 2022, filed 16 May 2022.